Akute und chronische Herzinsuffizienz im Spiegel der neuen ESC-Leitlinie-Reference-Cited by-同舟云学术

Akute und chronische Herzinsuffizienz im Spiegel der neuen ESC-Leitlinie

Published:2013-10-23 Issue:8 Volume:38 Page:812-820
ISSN:0340-9937
Container-title:Herz
language:de
Short-container-title:Herz

Author:

Pöss J.,Link A.,Böhm M.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00059-013-3986-9.pdf

Reference46 articles.

1. McMurray JJ, Adamopoulos S, Anker SD et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33(14):1787–1847

2. Pöss J, Ewen S, Link A et al (2013) Acute and chronic heart failure – innovations of the new ESC guidelines and their underlying clinical trials. Dtsch Med Wochenschr 138(25–26):1360–1364

3. Böhm M (2013) CardioUpDate, Handbuch Kardiologie. Springer, Berlin Heidelberg New York

4. o A (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 316(23):1429–1435

5. o A (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 325(5):293–302

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abaloparatid – eine neue osteoanabole Therapieoption für die Osteoporose bei postmenopausalen Frauen;Osteologie;2024-07-10

2. Exploring risk factors of short-term readmission in heart failure patients: A cohort study;Frontiers in Endocrinology;2022-11-28

3. Effect of combination antihypertensive therapy, including renin-angiotensin-aldosterone system inhibitors, on oxidative stress and arterial remodeling in hypertensive patients with heart failure with preserved ejection fraction;Russian Journal of Cardiology;2021-06-11

4. Serum NT‑proBNP and TUG1 as novel biomarkers for elderly hypertensive patients with heart failure with preserved ejection fraction;Experimental and Therapeutic Medicine;2021-03-01

5. Neue Medikamente in der Kardiologie;Der Internist;2014-03-13